MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    Bacterial biofilm formation on neurostimulation systems

    A. Wloch, B. Hong, M. Abdallat, A. Winkel, A. Saryyeva, G. Lütjens, M. Stiesch, J.K. Krauss (Hannover, Germany)

    Objective: The aim of this study is to identify specifically the DNA of bacterial biofilm on neurostimulation systems using polymerase chain reaction (PCR). Background: Bacterial…
  • 2016 International Congress

    Influence of onset age on the progression of non-motor symptoms in Parkinson’s disease: A prospective study from Southwest China

    R. Ou, B. Cao, Q. Wei, K. Chen, W. Song, J. Yang, B. Zhao, Y. Wu, H. Shang (Chengdu, People's Republic of China)

    Objective: To explore the influence of onset age on the progression of non-motor symptoms (NMS) in Parkinson's disease. Background: NMS are gaining increasing relevance in…
  • 2016 International Congress

    Microglia P2Y6 receptor is related to Parkinson’s disease and involved in the neuroinflammatory process

    X. Yang, Y. Lou, X. Wang, G. Liu, Y. Qian, J. Ding, S. Chen, Q. Xiao (Shanghai, People's Republic of China)

    Objective: To investigate whether the purinoceptor P2Y6 can be used as a biomarker in the diagnosis and treatment of Parkinson's disease (PD) and the role…
  • 2016 International Congress

    EBM review on the diagnostic work-up of multiple system atrophy

    I. Stankovic, A. Antonini, A. Berardelli, C. Colosimo, A. Fanciulli, S. Fox, B. Frauscher, H. Kaufmann, V.S. Kostic, F. Krismer, P. Low, W. Meissner, M.T. Pellecchia, W. Poewe, K. Seppi, S. Tsui, H. Watanabe, G.K. Wenning, On behalf of the MODIMSA EBM Working Group (Belgrade, Serbia)

    Objective: The International Parkinson and Movement Disorder Society (MDS)-endorsed MSA study group (MODIMSA) identified an urgent need to develop evidence-based recommendations for the diagnostic work-up…
  • 2016 International Congress

    Cognitive functioning in Parkinson’s disease and Parkinson plus syndrome

    S. Mina, V.K. Verma, K.S. Anand (New Delhi, India)

    Objective: Our study aimed to investigate and compare the cognitive functioning in PD and PPS. Background: Parkinson[s] disease (PD) is now known to be associated…
  • 2016 International Congress

    Multiple system atrophy: A comparison between clinical subtypes

    L.B. Barcelos, R.A. Saba, S.M.A. Silva, V. Borges, H.B. Ferraz (Sao Paulo, Brazil)

    Objective: To evaluate the cognitive impairment and sleep disturbances in subtype MSA-P versus MSA-C. Background: Multiple system atrophy (MSA) is a progressive neurodegenerative disorder of…
  • 2016 International Congress

    Rehabilitation of dysphagia in Parkinson’s disease: Effect of chin-down postural maneuver

    A. Ayres, G.P. Jotz, C.R.M. Rieder, M.R. Olchik (Porto Alegre, Brazil)

    Objective: To verify the effectiveness of chin-down posture maneuver in the rehabilitation of dysphagia with Parkinson's disease (PD). Background: Although dysphagia is a complicating symptom…
  • 2016 International Congress

    Assessment of olfactory dysfunction in Parkinson’s disease with an objective test

    Y. Sucullu Karadag, N. Turkmen, O. Gulten, A. Eryilmaz, A. Altundag, N. Subutay Oztekin, F. Ak (Ankara, Turkey)

    Objective: This study is aimed to investigate the frequency of olfactory dysfunction in PD and its possible relationship with motor/non-motor symptoms and treatments. Also the…
  • 2016 International Congress

    Does link between fatigue syndrome and camptocormia in patients with Parkinson’s disease exist?

    V. Datieva, O. Levin (Moscow, Russia)

    Objective: To study if there is link between camptocormia (CC) and fatigue syndrome (FS) in PD patients. Background: There is still no consensus on etiology…
  • 2016 International Congress

    Characterization of burning mouth syndrome in patients with Parkinson’s disease

    P.J. Blanchet, D. Bonenfant, P.H. Rompré, N. Rei, N. Jodoin, V.L. Soland, V. Rey, C. Brefel-Courbon, F. Ory-Magne, O. Rascol (Montreal, QC, Canada)

    Objective: To determine the prevalence and characteristics of burning mouth syndrome (BMS) in a Parkinson's disease (PD) population through a self-administered survey. Background: The majority…
  • « Previous Page
  • 1
  • …
  • 331
  • 332
  • 333
  • 334
  • 335
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Advanced Search
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley